Novo Nordisk A/S NVO | NYSE

$67.10 -$1.14 | -1.67%

After Hours
$67.08 -$0.02 | -0.03%

Next Earnings: May 07, 2025

Company Overview:

Market Cap: $294.63B
PE Ratio: 20.46
52-Week Range: $66.88 - $148.15
Dividend Yield (FWD): 3.28% ($2.20)

10 Year Performance Metrics:

Total Return (with DRIP): 238.69% (12.97% / yr)
Total Return (no DRIP): 185.14% (11.05% / yr)
Share Price: 142.41%
Dividend Increase: -46.82
NVO 10-yr Total Return ($10K invested)
1Y 2Y 5Y 10Y All

NVO Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
NVO Dividend CAGR:1Y: 18.21%2Y: 35.98%5Y: 7.03%10Y: 2.85%
Share Price
NVO Price CAGR:1Y: -47.16%2Y: -8.30%5Y: 17.53%10Y: 9.43%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

NVO Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend Payout Ratio - NVO
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - NVO
14-Day FREE Trial Get Full Access Now!

NVO Earnings, Revenue, Cash & Debt, Shares Outstaning:

NVO - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
NVO - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
NVO - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
NVO - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
NVO - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
NVO - Cash & Debt
14-Day FREE Trial Get Full Access Now!
NVO - Revenue
14-Day FREE Trial Get Full Access Now!
NVO Revenue CAGR:1Y: 30.09%2Y: 33.48%5Y: 21.46%10Y: 13.30%
NVO - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
NVO EPS CAGR:1Y: 28.92%2Y: 45.02%5Y: 11.46%10Y: 9.74%
NVO - Net Income
14-Day FREE Trial Get Full Access Now!
NVO Net Income CAGR:1Y: 28.53%2Y: 44.12%5Y: 26.49%10Y: 15.77%
NVO - EBITDA
14-Day FREE Trial Get Full Access Now!
NVO EBITDA CAGR:1Y: 31.13%2Y: 97.28%5Y: 33.36%10Y: 18.28%
NVO - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
NVO Free Cash Flow CAGR:1Y: -38.17%2Y: N/A5Y: N/A10Y: N/A
NVO - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
NVO Free Cash Flow / Share CAGR:1Y: -38.02%2Y: N/A5Y: N/A10Y: N/A
NVO - Gross Profit
14-Day FREE Trial Get Full Access Now!
NVO Gross Profit CAGR:1Y: 30.10%2Y: 35.06%5Y: 21.91%10Y: 13.44%
NVO - Expenses
14-Day FREE Trial Get Full Access Now!
NVO Expenses CAGR:1Y: 0.74%2Y: 63.78%5Y: 41.03%10Y: 26.62%
NVO - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
NVO Shares Outstanding CAGR:1Y: -0.38%2Y: -0.69%5Y: 13.49%10Y: 5.49%
NVO - Share Buybacks
14-Day FREE Trial Get Full Access Now!
NVO Share Buybacks CAGR:1Y: -23.26%2Y: -0.32%5Y: 8.73%10Y: 6.82%
NVO - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
NVO Stock-Based Comp CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: -100.00%
NVO - Dividends
14-Day FREE Trial Get Full Access Now!
NVO Dividend CAGR:1Y: 18.21%2Y: 35.98%5Y: 7.03%10Y: 2.85%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

NVO - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
NVO Actual Revenue CAGR:1Y: 30.09%2Y: 33.48%5Y: 21.46%10Y: 13.30%
NVO - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
NVO Actual EPS CAGR:1Y: 28.92%2Y: 45.02%5Y: 11.46%10Y: 9.74%
NVO - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
NVO Actual Net Income CAGR:1Y: 28.53%2Y: 44.12%5Y: 26.49%10Y: 15.77%
NVO - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
NVO Actual EBITDA CAGR:1Y: 31.13%2Y: 97.28%5Y: 33.36%10Y: 18.28%

Ratios, Profit Margins & Return on Capital:

NVO - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
NVO Net Profit Margin CAGR:1Y: -1.20%2Y: 7.98%5Y: 4.15%10Y: 2.18%
NVO - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
NVO Gross Profit Margin CAGR:1Y: 0.00%2Y: 1.19%5Y: 0.37%10Y: 0.13%
NVO - Price to Earnings
14-Day FREE Trial Get Full Access Now!
NVO - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
NVO - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
NVO - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!
Compare stocks side-by-side
 

NVO Dividends Info:

Annual Dividend: $2.20
Forward Yield: 3.28%
Ex-Dividend Date: 2025-03-31
Lifetime Dividens / Share: $17.35

NVO Dividend History: Dates, Payments & Yield list

Below is a schedule of all NVO dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
03/31/202504/08/2025$1.0992.32%3.17%$69.44
08/16/202408/26/2024$0.5131.07%0.76%$134.89
03/22/202404/02/2024$0.9301.07%1.44%$128.76
08/18/202308/29/2023$0.4421.13%0.97%$91.57
03/24/202304/04/2023$0.5951.16%1.56%$76.38
08/12/202208/23/2022$0.5843.01%2.17%$53.75
03/25/202204/05/2022$1.0362.99%3.89%$53.26
08/16/202108/25/2021$0.5572.92%2.16%$51.63
03/26/202104/07/2021$0.9494.33%5.6%$33.89
08/14/202008/25/2020$0.5183.96%3.15%$32.88
03/27/202004/07/2020$0.7834.34%5.52%$28.37
08/16/201908/27/2019$0.4494.79%3.48%$25.83
03/22/201904/02/2019$0.7894.95%6.22%$25.36
08/17/201808/28/2018$0.4674.79%3.94%$23.73
03/23/201804/03/2018$0.6704.72%5.53%$24.25
08/17/201708/29/2017$0.4745.02%4.18%$22.67
03/23/201704/04/2017$0.6636.7%8%$16.58
08/11/201608/23/2016$0.4476.07%3.85%$23.23
03/18/201603/30/2016$0.9646.31%7.06%$27.31
03/19/201503/31/2015$0.7606.6%6.31%$24.10
03/21/201404/02/2014$0.8303.78%7.57%$21.95
03/21/201304/02/2013$0.6377.05%7.9%$16.12
03/22/201204/03/2012$0.4996.09%7.05%$14.17
03/24/201104/05/2011$0.3645.24%5.9%$12.32
03/25/201011/30/-0001$0.2813.59%7.19%$7.83
03/19/200911/30/-0001$0.2074.49%8.97%$4.61
03/13/200811/30/-0001$0.1772.57%5.15%$6.87
03/08/200703/20/2007$0.1225.2%5.8%$4.20
03/09/200611/30/-0001$0.0976.16%6.59%$2.93
03/10/200511/30/-0001$0.0845.58%5.92%$2.84
03/17/200411/30/-0001$0.0755.51%6.48%$2.30
03/26/200311/30/-0001$0.0523.13%6.26%$1.67
03/13/200211/30/-0001$0.0373.6%3.86%$1.91
03/21/200111/30/-0001$0.0322.54%3.2%$1.99
11/17/200011/30/-0001$0.0192.32%2.07%$1.82
03/24/200011/30/-0001$0.0232.82%3.32%$1.41
03/25/199911/30/-0001$0.0163.25%3.28%$1.00
03/27/199811/30/-0001$0.0161.71%2.01%$1.60
04/25/199711/30/-0001$0.0111.96%2.23%$1.01
05/01/199611/30/-0001$0.0092.39%2.61%$0.66
04/24/199611/30/-0001$0.0071.11%2.22%$0.65
04/24/199511/30/-0001$0.0082.75%3.29%$0.51
04/26/199411/30/-0001$0.0062.07%2.07%$0.54
04/22/199411/30/-0001$0.0061.06%2.11%$0.53
04/22/199311/30/-0001$0.0052.53%2.4%$0.45
04/28/199211/30/-0001$0.0061.46%2.93%$0.41
04/19/199111/30/-0001$0.0053.54%3.18%$0.32
04/23/199011/30/-0001$0.0062.84%5.67%$0.22
04/21/198911/30/-0001$0.0052.2%4.41%$0.21
04/21/198811/30/-0001$0.0053.73%7.46%$0.14
04/20/198711/30/-0001$0.0043.99%4.36%$0.19
04/21/198611/30/-0001$0.0032.02%4.05%$0.17
04/19/198511/30/-0001$0.0031.99%3.98%$0.13
04/13/198411/30/-0001$0.0031.2%2.4%$0.24
04/13/198311/30/-0001$0.0031.28%2.11%$0.26
04/23/198211/30/-0001$0.0010.29%0.57%$0.21

Projected Future Returns & Dividends for NVO

Based on past 10-year performance, here are NVO growth metrics:

Share price CAGR of +9.39%
Dividend CAGR of +65.34%

Using NVO CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

NVO (DRIP)NVO - No DRIP
Current Price$67.10$67.10
Start Shares149.03149.03
Start Value$10,000$10,000
  
After 10 years:
Final Share Count4,265.91149.03
Dividends Payment$78.26$78.26
Annual Dividends$1,335,465$46,655
Yield on cost13,354.65%466.55%
Share Price$150.54$150.54
Total Dividends$591,697$70,937
Final Value$642,194$93,372

Estimated Future Value + Dividends - NVO

NOTE: Above numbers are our estimate based on NVO's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

Novo Nordisk A/S (NVO) had its IPO on 1981-04-30, and is trader on NYSE stock exchange.

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

NVO website: https://www.novonordisk.com

Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial